Alicia M. Neu

Alicia M. Neu

Auto-generated profile, based on publicly available information

Alicia M. Neu

Johns Hopkins University School of Medicine, Baltimore, Maryland

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2002 in Pediatric Nephrology
Verified
Journal Article
Closed access
PDF file
ANAlicia M. Neu
Alicia M. Neu
(H(Martin) P. Ho
(Martin) P. Ho
RMRuth A. McDonald
Ruth A. McDonald
BWBradley A. Warady
Bradley A. Warady

19 May 2003 in Pediatric Transplantation
Verified
Journal Article
Closed access
PDF file
ANAlicia M. Neu
Alicia M. Neu
PHP. L. (Martin) Ho
P. L. (Martin) Ho
RFRichard N. Fine
Richard N. Fine
SFSusan L. Furth
Susan L. Furth
BFBarbara A. Fivush
Barbara A. Fivush

24 July 2014 in Pediatric Nephrology
Verified
Journal Article
Closed access
PDF file
FPfor the SCOPE Collaborative Participants
for the SCOPE Collaborative Participants
ANAlicia M Neu
Alicia M Neu
MMMarlene R Miller
Marlene R Miller
JSJayne Stuart
Jayne Stuart
JLJohn Lawlor
John Lawlor
BWBradley A. Warady
Bradley A. Warady

1 June 2016 in Kidney International
Verified
Journal Article
Closed access
ANAlicia M Neu
Alicia M Neu
TRTroy Richardson
Troy Richardson
JLJohn Lawlor
John Lawlor
JSJayne Stuart
Jayne Stuart
JNJason Newland
Jason Newland
SPSCOPE Collaborative Participants
SCOPE Collaborative Participants

1 July 2012 in Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis
Verified
Journal Article
Open access
PDF file
ANAlicia M. Neu
Alicia M. Neu
ASAnja Sander
Anja Sander
DBDagmara Borzych–Dużałka
Dagmara Borzych–Dużałka
AWAlan R. Watson
Alan R. Watson
PVPatricia G. Vallés
Patricia G. Vallés
BWBradley A. Warady
Bradley A. Warady
♦ Background, Objectives, and Methods: Hospitalization and mortality rates in pediatric dialysis patients remain unacceptably high. Although studies have associated the presence of comorbidities with an increased risk for death in a relatively small number of pediatric dialysis patients, no large-scale study had set out to describe the comorbidities seen in pediatric dialysis patients or to evaluate the impact of those comorbidities on outcomes beyond the newborn period. In the present study, we evaluated the prevalence of comorbidities in a large international cohort of pediatric chronic peritoneal dialysis (CPD) patients from the International Pediatric Peritoneal Dialysis Network registry and began to assess potential associations between those comorbidities and hospitalization rates and mortality.

3 November 2011 in Pediatric Nephrology
Verified
Journal Article
Open access
PDF file
ANAlicia M. Neu
Alicia M. Neu
Children with chronic kidney disease (CKD) are at increased risk for vaccine-preventable diseases. These patients may have a reduced response to and/or reduced duration of antibody after immunization and therefore monitoring of antibody levels or titers is indicated for some vaccines. In addition, pediatric CKD patients require immunizations not routinely provided to healthy children. Unfortunately, studies in pediatric CKD patients, including those on dialysis and awaiting kidney transplantation, have demonstrated sub-optimal immunization rates. In order to minimize the risk for vaccine-preventable disease in pediatric CKD patients, it is imperative that all who care for these patients remain abreast of the recommended childhood immunization schedule, as well as alterations to this schedule required for children with CKD, including end-stage kidney disease. This article reviews recent changes to the recommended childhood immunization schedule and alterations and additions to this schedule recommended for children with CKD. Where available, data on antibody response to immunizations in children with CKD are presented.